insights_auto
Waarom is BOT gedaald 20,00%?
Meer informatiechevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
AU$ 0,0080
arrow_downward
-20,00%(-0,0020) 1D
20 nov, 16:10:07 GMT+11 · AUD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor BOT genereren…
Openen
AU$ 0,01
Hoog
AU$ 0,01
Laag
AU$ 0,01
Beursw.
22,10 mln.
Gem. vol.
11,07 mln.
Volume
8,60 mln.
52 wk hoog
AU$ 0,15
52 wk laag
AU$ 0,01
WPA
AU$ -0,03
Uitstaande aandelen
2,76 mld.
Aantal medewerkers
11
Openen
AU$ 0,01
Hoog
AU$ 0,01
Laag
AU$ 0,01
Beursw.
22,10 mln.
Gem. vol.
11,07 mln.
Volume
8,60 mln.
52 wk hoog
AU$ 0,15
52 wk laag
AU$ 0,01
WPA
AU$ -0,03
Uitstaande aandelen
2,76 mld.
Aantal medewerkers
11
Nieuwsartikelen
Van webbronnen en nieuwspartners
AP News
·
1 dag geleden
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
3 uur geleden
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Beinsure
·
17 uur geleden
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
WSJ
·
2 dagen geleden
Dow, S&P 500 Poised to Close at a Correction
Profiel
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Over Botanix Pharmaceuticals Ltd